Wayfinder Biosciences
5 known investors
Wayfinder Bio develops orally available small-molecule medicines that bind to the mRNAs encoding disease-driving proteins to prevent those proteins from being made. Its platform combines RNA-based sensors with experimental and AI/ML screening to discover selective RNA-targeting small molecules, with a pipeline spanning oncology, neurodegeneration, and other disease areas.
AI & Machine LearningBiotechDeep Tech
Investors · 5
In the news
Frequently asked questions
- What does Wayfinder Biosciences do?
- Wayfinder Bio develops orally available small-molecule medicines that bind to the mRNAs encoding disease-driving proteins to prevent those proteins from being made. Its platform combines RNA-based sensors with experimental and AI/ML screening to discover selective RNA-targeting small molecules, with a pipeline spanning oncology, neurodegeneration, and other disease areas.
- Who are Wayfinder Biosciences's investors?
- Wayfinder Biosciences's investors include Notation Capital, Social Starts, BoxOne Ventures, Divergent Capital, Exor Ventures.